Christopher S. Lunde

902 total citations
20 papers, 667 citations indexed

About

Christopher S. Lunde is a scholar working on Molecular Biology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christopher S. Lunde has authored 20 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Infectious Diseases and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christopher S. Lunde's work include Antimicrobial Resistance in Staphylococcus (4 papers), Photoreceptor and optogenetics research (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Christopher S. Lunde is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Photoreceptor and optogenetics research (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). Christopher S. Lunde collaborates with scholars based in United States, Germany and United Kingdom. Christopher S. Lunde's co-authors include Isao Kubo, Bret M. Benton, P.P.A. Humphrey, James W. Janc, Mathai Mammen, Sang Hwa Lee, Robert M. Glaeser, Shahab Rouhani, Yang Song and Brian J. Wilkinson and has published in prestigious journals such as Nature Communications, Journal of Agricultural and Food Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Christopher S. Lunde

20 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher S. Lunde United States	13	227	183	138	111	102	20	667
Xingyuan Cao China	20	331 1.5×	136 0.7×	221 1.6×	205 1.8×	63 0.6×	79	1.1k
Terence I. Moy United States	16	884 3.9×	221 1.2×	99 0.7×	119 1.1×	95 0.9×	18	1.4k
Gabriele Casadei Italy	13	389 1.7×	145 0.8×	158 1.1×	67 0.6×	119 1.2×	25	957
Silvia Altabe Argentina	20	634 2.8×	81 0.4×	90 0.7×	176 1.6×	40 0.4×	37	1.1k
Noemi Nosomi Taniwaki Brazil	20	336 1.5×	76 0.4×	97 0.7×	197 1.8×	154 1.5×	61	1.1k
Syed Babar Jamal Pakistan	16	335 1.5×	113 0.6×	46 0.3×	44 0.4×	77 0.8×	59	809
Jin‐Hwan Kwak South Korea	18	438 1.9×	176 1.0×	83 0.6×	144 1.3×	167 1.6×	47	984
M. Midgley United Kingdom	16	642 2.8×	145 0.8×	92 0.7×	79 0.7×	76 0.7×	41	1.1k
J.M. Castro Spain	23	707 3.1×	208 1.1×	419 3.0×	102 0.9×	31 0.3×	50	1.4k
Jiangwei Yao United States	22	676 3.0×	320 1.7×	167 1.2×	60 0.5×	143 1.4×	34	1.3k

Countries citing papers authored by Christopher S. Lunde

Since Specialization

Citations

This map shows the geographic impact of Christopher S. Lunde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Lunde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Lunde more than expected).

Fields of papers citing papers by Christopher S. Lunde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Lunde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Lunde. The network helps show where Christopher S. Lunde may publish in the future.

Co-authorship network of co-authors of Christopher S. Lunde

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Lunde. A scholar is included among the top collaborators of Christopher S. Lunde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Lunde. Christopher S. Lunde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cummings, Jason E., Christopher S. Lunde, M.R. Alley, & Richard A. Slayden. (2023). Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of ceftazidime against Burkholderia pseudomallei, the causative agent of melioidosis. PLoS neglected tropical diseases. 17(11). e0011795–e0011795. 2 indexed citations

Ehrens, Alexandra, Christopher S. Lunde, Robert T. Jacobs, et al.. (2020). In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis. PLoS neglected tropical diseases. 14(1). e0007957–e0007957. 12 indexed citations

Lunde, Christopher S., Erin E. Stebbins, Rajiv S. Jumani, et al.. (2019). Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. Nature Communications. 10(1). 2816–2816. 44 indexed citations

Carter, David S., Robert T. Jacobs, Yvonne R. Freund, et al.. (2019). Macrofilaricidal Benzimidazole–Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs. ACS Infectious Diseases. 6(2). 180–185. 16 indexed citations

Song, Yang, Christopher S. Lunde, Bret M. Benton, & Brian J. Wilkinson. (2013). Studies on the Mechanism of Telavancin Decreased Susceptibility in a Laboratory-Derived Mutant. Microbial Drug Resistance. 19(4). 247–255. 9 indexed citations

Wang, Ting, Christopher S. Lunde, Shahab Rouhani, et al.. (2013). Deprotonation of D96 in Bacteriorhodopsin Opens the Proton Uptake Pathway. Structure. 21(2). 290–297. 32 indexed citations

Krause, Kevin M., Johanne Blais, Christopher S. Lunde, et al.. (2012). In vitro activity of telavancin and occurrence of vancomycin heteroresistance in isolates from patients enrolled in phase 3 clinical trials of hospital-acquired pneumonia. Diagnostic Microbiology and Infectious Disease. 74(4). 429–431. 13 indexed citations

Song, Yang, Christopher S. Lunde, Bret M. Benton, & Brian J. Wilkinson. (2012). Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies. Antimicrobial Agents and Chemotherapy. 56(6). 3157–3164. 28 indexed citations

Lunde, Christopher S., et al.. (2010). Fluorescence Microscopy Demonstrates Enhanced Targeting of Telavancin to the Division Septum ofStaphylococcus aureus. Antimicrobial Agents and Chemotherapy. 54(5). 2198–2200. 27 indexed citations

10.

Lunde, Christopher S., et al.. (2009). Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II. Antimicrobial Agents and Chemotherapy. 53(8). 3375–3383. 136 indexed citations

11.

Lunde, Christopher S., Shahab Rouhani, Jonathan Remis, & Robert M. Glaeser. (2008). Microcrystal screening with a novel design for beamline-mountable crystallization wells. Journal of Applied Crystallography. 41(2). 483–486. 2 indexed citations

12.

Benton, Bret M., Eefjan Breukink, Dmitri Debabov, et al.. (2007). O258 Telavancin inhibits peptidoglycan biosynthesis through preferential targeting of transglycosylation: evidence for a multivalent interaction between telavancin and lipid II. International Journal of Antimicrobial Agents. 29. S51–S52. 10 indexed citations

13.

Lunde, Christopher S., Shahab Rouhani, Marc T. Facciotti, & Robert M. Glaeser. (2006). Membrane-protein stability in a phospholipid-based crystallization medium. Journal of Structural Biology. 154(3). 223–231. 11 indexed citations

14.

Lunde, Christopher S., Shahab Rouhani, Jonathan Remis, et al.. (2005). UV microscopy at 280 nm is effective in screening for the growth of protein microcrystals. Journal of Applied Crystallography. 38(6). 1031–1034. 15 indexed citations

15.

Kubo, Isao, et al.. (2003). Modes of Antifungal Action of (2E)-Alkenals againstSaccharomyces cerevisiae. Journal of Agricultural and Food Chemistry. 51(14). 3951–3957. 28 indexed citations

16.

Rouhani, Shahab, Marc T. Facciotti, Christian N. Cunningham, et al.. (2002). Crystallization of membrane proteins from media composed of connected‐bilayer gels. Biopolymers. 66(5). 300–316. 9 indexed citations

17.

Lunde, Christopher S. & Isao Kubo. (2000). Effect of Polygodial on the Mitochondrial ATPase of Saccharomyces cerevisiae. Antimicrobial Agents and Chemotherapy. 44(7). 1943–1953. 93 indexed citations

18.

Lee, Sang Hwa, et al.. (1999). In Vitro Antifungal Susceptibilities of Candida albicans and Other Fungal Pathogens to Polygodial, a Sesquiterpene Dialdehyde. Planta Medica. 65(3). 204–208. 52 indexed citations

19.

Lunde, Christopher S., et al.. (1996). Indole and (E)-2-hexenal, phytochemical potentiators of polymyxins against Pseudomonas aeruginosa and Escherichia coli. Antimicrobial Agents and Chemotherapy. 40(6). 1438–1441. 14 indexed citations

20.

Lunde, Christopher S., et al.. (1995). Antimicrobial Activity of the Olive Oil Flavor Compounds. Journal of Agricultural and Food Chemistry. 43(6). 1629–1633. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact